Sheri Keitz to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Sheri Keitz has written about Randomized Controlled Trials as Topic.
Connection Strength
0.142
-
Scales CD, Norris RD, Keitz SA, Peterson BL, Preminger GM, Vieweg J, Dahm P. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol. 2007 Mar; 177(3):1090-4; discussion 1094-5.
Score: 0.051
-
Wang Y, Parpia S, Couban R, Wang Q, Armijo-Olivo S, Bassler D, Briel M, Brignardello-Petersen R, Gluud LL, Keitz SA, Letelier LM, Ravaud P, Schulz KF, Siemieniuk RAC, Zeraatkar D, Guyatt GH. Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors. J Clin Epidemiol. 2024 Jan; 165:111211.
Score: 0.040
-
Wang Y, Ghadimi M, Wang Q, Hou L, Zeraatkar D, Iqbal A, Ho C, Yao L, Hu M, Ye Z, Couban R, Armijo-Olivo S, Bassler D, Briel M, Gluud LL, Glasziou P, Jackson R, Keitz SA, Letelier LM, Ravaud P, Schulz KF, Siemieniuk RAC, Brignardello-Petersen R, Guyatt GH. Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues. J Clin Epidemiol. 2022 Dec; 152:218-225.
Score: 0.038
-
Kennedy CC, Jaeschke R, Keitz S, Newman T, Montori V, Wyer PC, Guyatt G. Tips for teachers of evidence-based medicine: adjusting for prognostic imbalances (confounding variables) in studies on therapy or harm. J Gen Intern Med. 2008 Mar; 23(3):337-43.
Score: 0.013